Pravin Kaumaya | Professor of Microbiology and Immunology
Indiana University School of Medicine

Pravin Kaumaya, Professor of Microbiology and Immunology, Indiana University School of Medicine

Kaumaya is Professor of Medicine in Department of Ob/Gyn at the OSU Wexner Medical Center and the James Comprehensive Cancer Center. Dr Kaumaya is internationally recognized as an expert in the fields of vaccine research with emphasis on peptide vaccines for cancer, viral diseases as well as peptide therapy for autoimmune diseases. He conducts research in the areas of tumor immunology, mechanisms of tumor cell-immune cell interactions, and immune mechanisms. The laboratory functions as an integrated translational research program with the goal of designing and developing new immunotherapies and immunologic strategies for cancer treatment and prevention. He is an inventor on several issued and pending patents for Peptide Vaccines and Therapeutic Technologies. He has lectured worldwide and has published over 130 peer-reviewed articles in major scientific journals Dr. Kaumaya is an elected fellow of the American Association for the Advancement of Science (AAAS), and he was elected as the treasurer of the American Peptide Society since 2009. Dr Kaumaya has conducted a first man/woman NCI funded and FDA approved Phase 1 Trial in Cancer Patients (Stage 4) with solid tumors in several indications (Breast, Ovarian, GIST) at the OSU James Cancer Hospital has recently been completed successfully.


Day 2 - November 29 @ 12:20

Combination Vaccines (PD-1, PD-L1, CTLA-4, TIGIT, LAG3)

last published: 02/Jan/24 12:15 GMT

back to speakers